Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Effect of Lutein on L-NAME-Induced Hypertensive Rats.

Sung JH, Jo YS, Kim SJ, Ryu JS, Kim MC, Ko HJ, Sim SS.

Korean J Physiol Pharmacol. 2013 Aug;17(4):339-45. doi: 10.4196/kjpp.2013.17.4.339. Epub 2013 Jul 30.

2.

Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats.

Saravanakumar M, Raja B.

Eur J Pharmacol. 2011 Dec 5;671(1-3):87-94. doi: 10.1016/j.ejphar.2011.08.052. Epub 2011 Sep 16.

PMID:
21937012
3.

Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats.

Khattab M, Ahmad M, Al-Shabanah OA, Raza M.

Receptors Channels. 2004;10(5-6):147-57.

PMID:
15989079
4.

Antihypertensive and cardioprotective effects of the Lagenaria siceraria fruit in NG-nitro-L-arginine methyl ester (L-NAME) induced hypertensive rats.

Mali VR, Mohan V, Bodhankar SL.

Pharm Biol. 2012 Nov;50(11):1428-35. doi: 10.3109/13880209.2012.684064. Epub 2012 Sep 21.

PMID:
22994444
5.

Effect of Viscum articulatum Burm. (Loranthaceae) in Nω-nitro-L-arginine methyl ester induced hypertension and renal dysfunction.

Bachhav SS, Bhutada MS, Patil SD, Baser B, Chaudhari KB.

J Ethnopharmacol. 2012 Jul 13;142(2):467-73. doi: 10.1016/j.jep.2012.05.021. Epub 2012 May 22.

PMID:
22626924
6.

Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.

Hropot M, Langer KH, Wiemer G, Grötsch H, Linz W.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Mar;367(3):312-7. Epub 2003 Jan 25.

PMID:
12644905
7.

Physical training prevents oxidative stress in L-NAME-induced hypertension rats.

Cardoso AM, Martins CC, Fiorin Fda S, Schmatz R, Abdalla FH, Gutierres J, Zanini D, Fiorenza AM, Stefanello N, Serres JD, Carvalho F, Castro VP, Mazzanti CM, Royes LF, Belló-Klein A, Goularte JF, Morsch VM, Bagatini MD, Schetinger MR.

Cell Biochem Funct. 2013 Mar;31(2):136-51. doi: 10.1002/cbf.2868. Epub 2012 Sep 7.

PMID:
22961602
8.

The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.

Tsukamoto O, Minamino T, Sanada S, Okada K, Hirata A, Fujita M, Shintani Y, Yulin L, Asano Y, Takashima S, Yamasaki S, Tomoike H, Hori M, Kitakaze M.

Cardiovasc Drugs Ther. 2006 Apr;20(2):93-102.

PMID:
16761190
9.

Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in L-NAME-induced hypertensive rats: a dose-dependence study.

Kumar S, Prahalathan P, Raja B.

Redox Rep. 2011;16(5):208-15. doi: 10.1179/1351000211Y.0000000009.

PMID:
22005341
10.

Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension.

Nakmareong S, Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, Sompamit K, Phisalaphong C.

Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):519-29. doi: 10.1007/s00210-011-0624-z. Epub 2011 Mar 30.

PMID:
21448566
11.

Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.

Valentin JP, Bessac AM, Maffre M, John GW.

Eur J Pharmacol. 1996 Dec 19;317(2-3):335-42.

PMID:
8997619
12.

Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.

de Gracia MC, Osuna A, O'Valle F, del Moral RG, Wangensteen R, del Rio CG, Vargas F.

J Am Soc Nephrol. 2000 Nov;11(11):1995-2000.

13.

Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor.

Abd El Motteleb DM, Elshazly SM.

Eur J Pharmacol. 2013 Nov 15;720(1-3):158-65. doi: 10.1016/j.ejphar.2013.10.033. Epub 2013 Oct 24.

PMID:
24238127
14.

Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats.

Kanematsu Y, Yamaguchi K, Ohnishi H, Motobayashi Y, Ishizawa K, Izawa Y, Kawazoe K, Kondo S, Kagami S, Tomita S, Tsuchiya K, Tamaki T.

Am J Physiol Renal Physiol. 2008 Nov;295(5):F1457-62. doi: 10.1152/ajprenal.00621.2007. Epub 2008 Aug 27.

16.

Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.

Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A.

Br J Pharmacol. 1995 Apr;114(7):1403-13.

17.

Antidiabetic and antihypertensive effect of a polyphenol-rich fraction of Thymelaea hirsuta L. in a model of neonatal streptozotocin-diabetic and N(G) -nitro-l-arginine methyl ester-hypertensive rats.

Bnouham M, Benalla W, Bellahcen S, Hakkou Z, Ziyyat A, Mekhfi H, Aziz M, Legssyer A.

J Diabetes. 2012 Sep;4(3):307-13. doi: 10.1111/j.1753-0407.2012.00202.x.

PMID:
22519949
18.

Prevention of cardiac dysfunction, kidney fibrosis and lipid metabolic alterations in l-NAME hypertensive rats by sinapic acid--Role of HMG-CoA reductase.

Silambarasan T, Manivannan J, Raja B, Chatterjee S.

Eur J Pharmacol. 2016 Apr 15;777:113-23. doi: 10.1016/j.ejphar.2016.03.004. Epub 2016 Mar 2.

PMID:
26945821
19.
20.

Role of nitric oxide in regional blood flow in angiotensin II-induced hypertensive rats.

Nishiyama A, Fujisawa Y, Fukui T, Rahman M, Kondo N, Ogawa Y, Fanzhu L, Guoxing Z, Kimura S, Abe Y.

Hypertens Res. 2001 Jul;24(4):421-7.

Supplemental Content

Support Center